14-day Premium Trial Subscription Try For FreeTry Free

Why Amarin Stock Is Poised for a Healthy 2020

11:30am, Friday, 17'th Jan 2020
Amarin (NASDAQ:AMRN) stock has been choppy for the past year, as the price has made multiple attempts to move above the $23-$24 range. However, this has been a stubborn line of resistance, considering
AstraZeneca (AZN) to discontinue STRENGTH study on its fish-oil pill Epanova in mixed dyslipidaemia on recommendation of an independent Data Monitoring Committee
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 13.) Arvinas Inc (...
Toward the end of trading Monday, the Dow traded up 0.17% to 28872.00 while the NASDAQ rose 0.88% to 9,259.66. The S&P also rose, gaining 0.56% to 3,283.62. Leading and...
Midway through trading Monday, the Dow traded up 0.20% to 28881.58 while the NASDAQ rose 0.49% to 9223.50. The S&P also rose, gaining 0.38% to 3277.76. Leading and Lagging...
Following the market opening Monday, the Dow traded up 0.07% to 28,844.56 while the NASDAQ rose 0.38% to 9,213.47. The S&P also rose, gaining 0.26% to 3,273.88. Leading and...
Acasti Pharma downgraded to Neutral from Buy at B. Riley FBR B. Riley FBR ACST
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE